Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tropical fish study offers insight into MS
Findings could have implications for human medicine

Insights gained from a study of tropical fish could improve our understanding of the nervous system, and even enhance the treatment of human conditions such as multiple sclerosis (MS).

By studying zebrafish, scientists at the University of Edinburgh uncovered vital clues about the production of myelin - a fatty sheath that insulates and protects the nerve fibres.

As myelin allows nerve impulses to be transmitted quickly, it is essential for good health. When it breaks down and is not repaired properly, it can lead to the debilitating symptoms of MS.

Zebrafish were used in the study as they share more than 80 per cent of the genes linked to human diseases, and exhibit very similar drug responses to humans. As young zebrafish are transparent, researchers were able to view their living nervous system without invasive surgery.

As a result of the study, scientists were able to quantify the time frame for developing myelin for the first time.

The findings demonstrate that the individual cells in the brain and central nervous system only have a matter of hours in which to generate the protective coating.

Following this, the team at Edinburgh are now investigating the ways in which gene manipulation and drugs could promote myelin generation in zebrafish.

Researcher at the university, Dr David Lyons, said: "To enhance myelin repair, we will need to improve either their ability to make myelin during the short time in which they have to do this, or find a way to allow them to produce myelin for a longer period of time."

The study, which has been published in Developmental Cell, offers hope for future treatments of myelin-related disorders in humans.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.